ORFV can carry TRAP gene expression via intracellular CRISPR/Cas9 gene editing technology

被引:1
作者
Yu, YongZhong [1 ]
Zhang, Fan [1 ]
Duan, Xuyang [1 ]
Yang, ChaoQun [1 ]
Cui, YuDong [1 ]
Yu, Li [2 ]
机构
[1] Heilongjiang Bayi Agr Univ, Coll Biol Sci & Technol, Daqing 163319, Peoples R China
[2] Chinese Acad Agr Sci, Harbin Vet Res Inst, Div Livestock Infect Dis, State Key Lab Vet Biotechnol, 427 Maduan St, Harbin 150001, Peoples R China
关键词
Orf virus; Staphylococcus aureus; TRAP; CRISPR; Cas9; technique; ORFV-TRAP recombinant virus; ENDOTHELIAL GROWTH-FACTOR; VIRUS-INFECTION; PARAPOXVIRUSES; IMMUNITY; GENOMES; PROTEIN; TARGET;
D O I
10.1016/j.jviromet.2022.114652
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Orf is an acute and highly contracted human and animal infection caused by orf virus (ORFV), which mainly affects sheep, goats, and other species. Clinically, opportunistic or conditional pathogens such as Staphylococcus aureus (S. aureus) are often detected in cases of orf, which greatly increases the risk of disease progression and clinical death. It has been reported that TRAP gene products of S. aureus can broadly influence bacterial life and pathogenicity in vivo, and introduction of exogenous TRAP genes may help to inhibit the proliferation of bacteria. In order to achieve the combined control of ORFV and S. aureus, a novel approach to design a S. aureus TRAP gene vaccine using a live attenuated ORFV vector is proposed. In this study, CRISPR/Cas9 gene editing technology was used to disable vascular endothelial growth factor E of ORFV (VEGF-v) and introduced TRAP gene into this position. TRAP gene expression was detected in keratinocytes infected with recombinant virus. The construction and experimental verification of recombinant ORFV (ORFV-v/TRAP) will provide a reference for indepth studies on the prevention and control of mixed infectious disease.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Xenotransplantation: The Contribution of CRISPR/Cas9 Gene Editing Technology
    Stewart, Zoe A.
    CURRENT TRANSPLANTATION REPORTS, 2022, 9 (04) : 268 - 275
  • [2] Therapeutic applications of CRISPR/Cas9 gene editing technology for the treatment of ocular diseases
    Sundaresan, Yogapriya
    Yacoub, Sam
    Kodati, Bindu
    Amankwa, Charles E.
    Raola, Akash
    Zode, Gulab
    FEBS JOURNAL, 2023, 290 (22) : 5248 - 5269
  • [3] Therapeutic gene editing in haematological disorders with CRISPR/Cas9
    Jensen, Trine I.
    Axelgaard, Esben
    Bak, Rasmus O.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (05) : 821 - 835
  • [4] CRISPR/Cas9 Gene Editing System Can Alter Gene Expression and Induce DNA Damage Accumulation
    Yang, Lan
    Li, Hao
    Han, Yao
    Song, Yingjie
    Wei, Mingchen
    Fang, Mengya
    Sun, Yansong
    GENES, 2023, 14 (04)
  • [5] CRISPR/Cas9 gene editing technology: a precise and efficient tool for crop quality improvement
    Guo, Yingxin
    Zhao, Guangdong
    Gao, Xing
    Zhang, Lin
    Zhang, Yanan
    Cai, Xiaoming
    Yuan, Xuejiao
    Guo, Xingqi
    PLANTA, 2023, 258 (02)
  • [6] CRISPR/Cas9 gene editing therapies for cystic fibrosis
    Graham, Carina
    Hart, Stephen
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (06) : 767 - 780
  • [7] A glance at genome editing with CRISPR–Cas9 technology
    Antara Barman
    Bornali Deb
    Supriyo Chakraborty
    Current Genetics, 2020, 66 : 447 - 462
  • [8] The enhancement of CRISPR/Cas9 gene editing using metformin
    Rollins, Jaedyn L.
    Hall, Raquel M.
    Lemus, Clara J.
    Leisten, Lauren A.
    Johnston, Jennifer M.
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2023, 35
  • [9] Lipid and polymer mediated CRISPR/Cas9 gene editing
    Gong, Yan
    Tian, Siyu
    Xuan, Yang
    Zhang, Shubiao
    JOURNAL OF MATERIALS CHEMISTRY B, 2020, 8 (20) : 4369 - 4386
  • [10] ROS-responsive polypeptides for intracellular protein delivery and CRISPR/Cas9 gene editing
    Tan, Echua
    Wan, Tao
    Yu, Chunlei
    Fan, Qianqian
    Liu, Wenbang
    Chang, Hong
    Lv, Jia
    Wang, Hui
    Li, Dali
    Ping, Yuan
    Cheng, Yiyun
    NANO TODAY, 2022, 46